Momelotinib T1849
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Momelotinib is an orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with IC50 of 11 nM/18 nM. JAK1/2 inhibitor CYT387 competes with JAK1/2 for ATP binding, which may result in inhibition of JAK1/2 activation, inhibition of the
CAS nr:
1056634-68-4
Purity:
98%
Molecular Weight:
414,46
SMILES:
O=C(NCC#N)c1ccc(cc1)c1nc(Nc2ccc(cc2)N2CCOCC2)ncc1
Formula:
C23H22N6O2
Pathway:
JAK/STAT signaling,Chromatin/Epigenetic,Stem Cells,Angiogenesis,Apoptosis,Autophagy
Target:
JAK,JAK,JAK,JAK,Apoptosis,Autophagy
